|
MYC amplification and protein expression as prognostic markers in pediatric and young adult osteosarcoma. |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
|
Stock and Other Ownership Interests - Merck |
Consulting or Advisory Role - BirdsEye Bio |
|
| |
|
Stock and Other Ownership Interests - Day One Biopharmaceuticals; Novavax; Tango Therapeutics |
| |
|
No Relationships to Disclose |
| |
|
Honoraria - Foundation Medicine; Takeda |
Consulting or Advisory Role - Bayer; Bayer; Illumina; Ipsen |
Travel, Accommodations, Expenses - Bayer |